Viatris Return on Investment 2010-2024 | VTRS

Current and historical return on investment (ROI) values for Viatris (VTRS) over the last 10 years.
Viatris ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2024-03-31 $0.57B $36.09B 1.50%
2023-12-31 $0.77B $36.66B 1.96%
2023-09-30 $1.02B $39.59B 2.56%
2023-06-30 $1.13B $39.76B 2.83%
2023-03-31 $1.31B $40.72B 3.26%
2022-12-31 $1.62B $39.09B 4.02%
2022-09-30 $1.74B $39.65B 4.30%
2022-06-30 $1.54B $40.83B 3.72%
2022-03-31 $0.94B $41.10B 2.23%
2021-12-31 $-0.03B $40.21B -0.08%
2021-09-30 $-0.84B $43.05B -1.85%
2021-06-30 $-0.84B $44.37B -2.10%
2021-03-31 $-0.66B $45.99B -1.92%
2020-12-31 $-0.21B $47.87B -0.73%
2020-09-30 $0.94B $22.55B 4.11%
2020-06-30 $0.92B $21.64B 3.90%
2020-03-31 $0.88B $23.38B 3.58%
2019-12-31 $0.72B $24.06B 2.85%
2019-09-30 $0.68B $24.85B 2.66%
2019-06-30 $0.69B $25.62B 2.67%
2019-03-31 $0.77B $26.11B 2.96%
2018-12-31 $0.91B $25.33B 3.45%
2018-09-30 $1.09B $26.51B 4.07%
2018-06-30 $1.07B $26.58B 3.97%
2018-03-31 $1.37B $26.76B 4.98%
2017-12-31 $1.44B $27.41B 5.20%
2017-09-30 $1.33B $27.28B 4.80%
2017-06-30 $0.88B $28.23B 3.26%
2017-03-31 $0.82B $27.73B 3.18%
2016-12-31 $0.70B $27.68B 2.99%
2016-09-30 $0.81B $24.80B 3.96%
2016-06-30 $1.54B $23.10B 8.32%
2016-03-31 $1.41B $17.94B 8.30%
2015-12-31 $1.46B $16.06B 8.84%
2015-09-30 $1.43B $17.02B 9.47%
2015-06-30 $1.32B $16.84B 9.85%
2015-03-31 $1.27B $16.22B 10.28%
2014-12-31 $1.35B $10.31B 11.89%
2014-09-30 $1.23B $10.40B 10.49%
2014-06-30 $1.08B $12.57B 9.24%
2014-03-31 $1.16B $12.24B 10.63%
2013-12-31 $1.14B $11.82B 11.14%
2013-09-30 $1.13B $10.04B 11.72%
2013-06-30 $1.12B $9.61B 12.04%
2013-03-31 $1.07B $9.34B 11.80%
2012-12-31 $1.11B $9.46B 12.29%
2012-09-30 $1.09B $8.83B 12.37%
2012-06-30 $1.03B $8.75B 11.76%
2012-03-31 $1.04B $9.07B 11.87%
2011-12-31 $1.01B $8.73B 11.44%
2011-09-30 $0.85B $8.32B 9.56%
2011-06-30 $0.82B $9.06B 8.97%
2011-03-31 $0.74B $9.04B 8.17%
2010-12-31 $0.72B $9.25B 8.10%
2010-09-30 $0.69B $9.22B 7.85%
2010-06-30 $0.52B $8.49B 5.98%
2010-03-31 $0.50B $8.72B 5.78%
2009-12-31 $0.52B $8.62B 6.24%
Sector Industry Market Cap Revenue
Medical Medical Services $12.216B $15.427B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $124.295B 15.60
Cencora (COR) United States $47.007B 18.33
ICON (ICLR) Ireland $26.068B 24.61
DiDi Global (DIDIY) China $21.483B 0.00
Avantor (AVTR) United States $14.638B 21.55
CochLear (CHEOY) Australia $14.016B 0.00
Revvity (RVTY) United States $13.265B 23.27
Natera (NTRA) United States $13.164B 0.00
Medpace Holdings (MEDP) United States $12.413B 40.84
EUROFINS SCIENT (ERFSF) Luxembourg $10.939B 0.00
Charles River Laboratories (CRL) United States $10.798B 20.67
Solventum (SOLV) United States $9.292B 0.00
Sonic Healthcare (SKHHY) Australia $8.560B 0.00
HealthEquity (HQY) United States $7.157B 45.96
Bausch + Lomb (BLCO) Canada $5.309B 21.25
Organon (OGN) United States $5.259B 4.99
Doximity (DOCS) United States $5.034B 35.26
PACS (PACS) United States $4.404B 0.00
Life Times (LTH) United States $3.653B 38.27
Sotera Health (SHC) United States $3.278B 16.08
Surgery Partners (SGRY) United States $3.011B 27.55
GoodRx Holdings (GDRX) United States $2.927B 111.43
Agilon Health (AGL) United States $2.612B 0.00
Progyny (PGNY) United States $2.413B 41.54
NovoCure (NVCR) Jersey $2.063B 0.00
AMN Healthcare Services Inc (AMN) United States $2.019B 8.00
Premier (PINC) United States $1.914B 8.19
BrightSpring Health Services (BTSG) United States $1.785B 0.00
Teladoc Health (TDOC) United States $1.637B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.566B 0.00
Alignment Healthcare (ALHC) United States $1.356B 0.00
Establishment Labs Holdings (ESTA) $1.176B 0.00
CareDx (CDNA) United States $0.728B 0.00
Embecta (EMBC) United States $0.719B 4.89
GeneDx Holdings (WGS) United States $0.703B 0.00
Pediatrix Medical (MD) United States $0.649B 6.88
InnovAge Holding (INNV) United States $0.619B 0.00
Auna S.A (AUNA) Luxembourg $0.594B 0.00
Enhabit (EHAB) United States $0.442B 44.05
QDM (QDMI) Hong Kong, SAR China $0.437B 11.45
COMPASS Pathways (CMPS) United Kingdom $0.432B 0.00
ModivCare (MODV) United States $0.370B 6.93
Sonida Senior Living (SNDA) United States $0.370B 0.00
DocGo (DCGO) United States $0.313B 17.11
LifeMD (LFMD) United States $0.300B 0.00
Sharecare (SHCR) United States $0.281B 0.00
MultiPlan (MPLN) United States $0.247B 0.00
Sera Prognostics (SERA) United States $0.232B 0.00
Beauty Health (SKIN) United States $0.219B 0.00
Ascend Wellness Holdings (AAWH) United States $0.189B 0.00
Biodesix (BDSX) United States $0.185B 0.00
So-Young (SY) China $0.111B 53.55
Pono Capital Two (PTWO) United States $0.071B 0.00
Co-Diagnostics (CODX) United States $0.045B 0.00
NeueHealth (NEUE) United States $0.043B 5.83
IceCure Medical (ICCM) Israel $0.034B 0.00
Oncology Institute (TOI) United States $0.031B 0.00
Nutex Health (NUTX) United States $0.028B 0.00
Singular Genomics Systems (OMIC) United States $0.024B 0.00
OncoCyte (OCX) United States $0.024B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.023B 0.00
KindlyMD (KDLY) $0.017B 0.00
SeaStar Medical Holding (ICU) United States $0.016B 0.00
BIMI Holdings (BIMI) United States $0.015B 0.00
TRxADE HEALTH (MEDS) United States $0.013B 0.00
BioNexus Gene Lab (BGLC) $0.008B 0.00
XWELL (XWEL) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
ISpecimen (ISPC) United States $0.005B 0.00
DermTech (DMTK) United States $0.004B 0.00
OpGen (OPGN) United States $0.003B 0.00
NewGenIvf Group (NIVF) Singapore $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Assure Holdings (IONM) United States $0.001B 0.00